Citation Impact
Citing Papers
Transferred WT1-Reactive CD8 + T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
2013
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Heparin-Protein Interactions
2002 Standout
Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe
2002
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Toxoplasmosis
2004 Standout
Dasatinib
2009
Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature
2002
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Chronic myelogenous leukemia
2001
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16‐year period
1997
Ribosome-inactivating proteins from plants
1993
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
2016
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
The Outcomes and Costs of Acute Myeloid Leukemia Among the Elderly
2002
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis
1998
Treatment of severe acute graft‐versus‐host disease with anti‐thymocyte globulin
2001
Acute graft-vs-host disease
2001
Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target With Which They Interact
1993
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.
1998
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Staphylococcal and Streptococcal Pyrogenic Toxins Involved in Toxic Shock Syndrome and Related Illnesses
1990
Cancer genes and the pathways they control
2004 Standout
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration
2010
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Treating hepatitis C
2005 StandoutNobel
Graft-versus-host disease
2009 Standout
Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation
2003
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Chronic Myelogenous Leukemia
2002
OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
1995
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
2016
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
2004 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Molecular remission of chronic myeloid leukaemia following a non‐myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft‐versus‐leukaemia effect
1999
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Risk score for outcome after allogeneic hematopoietic stem cell transplantation
2009
Idarucizumab for Dabigatran Reversal
2015 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
2002
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
2002
Imatinib Mesylate — A New Oral Targeted Therapy
2002
A review of autologous hematopoietic cell transplantation
2000 Nobel
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Non-HLA immunogenetics in hematopoietic stem cell transplantation
2005
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
2005
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
2006
Infection in Organ-Transplant Recipients
1998 Standout
Extrathymic positive selection of αβ T-cell precursors in nude mice
1992 StandoutNatureNobel
Staphylococcus aureusInfections
1998 Standout
Unrelated donor bone marrow transplantation using a chemotherapy‐only preparative regimen for adults with high‐risk acute myelogenous leukemia
2006
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
2001
Specific Killing of Ph+Chronic Myeloid Leukemia Cells by a Lentiviral Vector-Delivered Anti-bcr/ablSmall Hairpin RNA
2003
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
2017
STI571: A Paradigm of New Agents for Cancer Therapeutics
2002
Acute Myeloid Leukemia
2015 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
2004
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides.
1992
The myth of the second remission of acute leukemia in the adult
2012
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Outcome of adults with acute lymphocytic leukemia after second salvage therapy
2008
Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
2012
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum
1994
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Chimeric Antigen Receptor Therapy
2018 Standout
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
2008 Standout
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification
2011
Selective IgG subclass deficiency: quantification and clinical relevance
1990
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia
2000
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA
1992
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Diagnosing and Managing Advanced Chronic Myeloid Leukemia
2015
CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57− subset and its progressive replacement by CD8+CD57+ T cells
1994
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Vascular toxicity associated with antineoplastic agents.
1986
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts
1989
Metal–Organic Frameworks in Biomedicine
2011 Standout
Large-scale analysis of the human and mouse transcriptomes
2002 StandoutNobel
Late Effects of Hematopoietic Cell Transplantation Among 10-Year Adult Survivors Compared With Case-Matched Controls
2005
CAR T cell immunotherapy for human cancer
2018 StandoutScience
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Chronic myeloid leukemia: current treatment options
2001
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation
2014
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of Vernant Jp being referenced
Allogeneic bone marrow transplantation for leukaemia in Europe
1988
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
1998
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine
1997
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial
2007
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society
2003
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)
1997
Functional analysis of CD8 lymphocytes in long-term surviving patients after bone marrow transplantation
1988
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis
1997
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma
2014
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
1999
Adult T‐biphenotypic acute leukaemia: clinical and biological features and outcome
2003
Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.
1990
Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease.
1989
Serum IgG subclasses in secondary immunodeficiencies.
1988
Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group
1995
Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation
1987
Pulmonary veno-occlusive disease after bone marrow transplantation.
1984
Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms
1987
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
1993
Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation.
1990
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
1996
RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
1991
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)
1995
Late toxoplasmosis evidenced by PCR in a marrow transplant recipient.
1995